Atsunori Saraya

Chuo, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

Generation of Mouse Primitive Endoderm Stem Cells.

Generation of Mouse Primitive Endoderm Stem Cells.

Journal: Bio-protocol
Published: July 30, 2023

Correction: UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease.

Correction: UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease.

Journal: Leukemia
Published: July 18, 2023

Polycomb repressive complex 1.1 coordinates homeostatic and emergency myelopoiesis.

Polycomb repressive complex 1.1 coordinates homeostatic and emergency myelopoiesis.

Journal: eLife
Published: August 26, 2022

UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease.

UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease.

Journal: Leukemia
Published: May 25, 2022

Establishment of mouse stem cells that can recapitulate the developmental potential of primitive endoderm.

Establishment of mouse stem cells that can recapitulate the developmental potential of primitive endoderm.

Journal: Science (New York, N.Y.)
Published: February 03, 2022

Insufficiency of non-canonical PRC1 synergizes with JAK2V617F in the development of myelofibrosis.

Insufficiency of non-canonical PRC1 synergizes with JAK2V617F in the development of myelofibrosis.

Journal: Leukemia
Published: January 22, 2021

Silencing of p53 and CDKN1A establishes sustainable immortalized megakaryocyte progenitor cells from human iPSCs.

Silencing of p53 and CDKN1A establishes sustainable immortalized megakaryocyte progenitor cells from human iPSCs.

Journal: Stem cell reports
Published: October 01, 2020

The combination of the tubulin binding small molecule PTC596 and proteasome inhibitors suppresses the growth of myeloma cells.

The combination of the tubulin binding small molecule PTC596 and proteasome inhibitors suppresses the growth of myeloma cells.

Journal: Scientific reports
Published: June 29, 2020

Bmi1 counteracts hematopoietic stem cell aging by repressing target genes and enforcing the stem cell gene signature.

Bmi1 counteracts hematopoietic stem cell aging by repressing target genes and enforcing the stem cell gene signature.

Journal: Biochemical and biophysical research communications
Published: September 11, 2019

Akt inhibition synergizes with polycomb repressive complex 2 inhibition in the treatment of multiple myeloma.

Akt inhibition synergizes with polycomb repressive complex 2 inhibition in the treatment of multiple myeloma.

Journal: Cancer science
Published: August 28, 2019

Bmi1 restricts the adipogenic differentiation of bone marrow stromal cells to maintain the integrity of the hematopoietic stem cell niche.

Bmi1 restricts the adipogenic differentiation of bone marrow stromal cells to maintain the integrity of the hematopoietic stem cell niche.

Journal: Experimental hematology
Published: July 27, 2019

KDM2B in polycomb repressive complex 1.1 functions as a tumor suppressor in the initiation of T-cell leukemogenesis.

KDM2B in polycomb repressive complex 1.1 functions as a tumor suppressor in the initiation of T-cell leukemogenesis.

Journal: Blood advances
Published: November 10, 2018
Showing 1-12 of 33

Last Updated: 09/26/2026